Pediatric Rheumatology

Article	Citations
Predictors of fibrogenesis in children with JIA: a single-center pilot study	46
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial	40
Algorithmic approach in the diagnosis of pediatric uveitis	36
Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators	31
Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus	25
Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC)	25
Peripheral blood regulatory T cells and disease activity, quality of life, and outcomes in children with juvenile idiopathic arthritis	25
The protective effect of COVID-19 vaccines on developing multisystem inflammatory syndrome in children (MIS-C): a systematic literature review and meta-analysis	24
Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study	23
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers’ perspectives	22
Musculoskeletal symptoms and their impact on health-related quality of life in chronic nonbacterial osteomyelitis patients	22
Clinical features, treatment, and outcomes of celiac-associated arthritis: a retrospective cohort study	22
The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource	22
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience	21
Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease	20
A randomized controlled educational study to evaluate an e-learning module to teach the physical examination of the temporomandibular joint in juvenile idiopathic arthritis	19
Neurological involvement in children with familial Mediterranean fever: a systematic review	17
Investigating the association between SARS-CoV-2 infection, COVID-19 vaccination, and autoimmune diseases in a pediatric population: a comprehensive analysis	17
A roadmap for navigating child health research data sharing across Canada and beyond – building on UCAN CAN-DU	17
Relationship of regional ultraviolet index data with rash and systemic disease activity in youth with childhood-onset systemic lupus: results from the Childhood Arthritis and Rheumatology Research All	17
Pediatric immune-mediated necrotizing myopathy with anti-SRP antibodies targeting 19, 68, and 72 kda subunits	17
Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center	16
Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study	16
Therapeutic recreation camps for youth with childhood-onset systemic lupus erythematosus: perceived psychosocial benefits	16
Cervical spine arthritis as initial manifestation in Juvenile Idiopathic Arthritis: a multicenter retrospective study	16

Proceedings of the 29th European Paediatric Rheumatology Congress	16
Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort	15
The clinical relevance of different antiphospholipid antibody profiles in pediatric rheumatology patients	15
Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (S	15
Frequency of remission achievement in the pre-treat-to-target decade in juvenile idiopathic arthritis	15
Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals	14
Development of the paediatric society of the African league against rheumatism (PAFLAR) JIA registry and clinical profile of JIA in Africa from the PAFLAR JIA registry	14
Natural autoimmunity in oligoarticular juvenile idiopathic arthritis	14
Correction: PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	14
Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study	14
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis	14
How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience	13
Body mass index is associated with health-related quality of life and disease characteristics in young adults with juvenile idiopathic arthritis	13
Identification of a variant in NLRP3 gene in a patient with Muckle-Wells syndrome: a case report and review of literature	13
Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis	13
Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana	13
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study	13
14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report	12
Serum bile salt-stimulated lipase levels associates with systemic inflammation and declines with effect of treatment in juvenile idiopathic arthritis	12
Screening for celiac disease in juvenile idiopathic arthritis	12
Exploring the clinical profiles and management of juvenile dermatomyositis in Africa: a survey of African rheumatology care providers	12
Long noncoding RNAs (CTC-471J1.2, NeST) as epigenetic risk factors of active juvenile lupus nephritis: a case-control study	12
An iceberg I can’t handle: a qualitative inquiry on perceptions towards paediatric rheumatology among healthcare workers in Kenya	11
Developing consensus outcome measures in juvenile systemic sclerosis: a global survey of pediatric rheumatologists and literature review	11
Economic evaluation of infliximab, synthetic triple therapy and methotrexate in the treatment of newly diagnosed juvenile idiopathic arthritis	11
Longitudinal assessment of preparation for care transition among adolescents and young adults with rheumatologic disease: a single-center pilot study	11
Differences between leukemic arthritis and juvenile idiopathic arthritis	11
Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases	11
Feasibility of quantitative sensory testing in juvenile idiopathic arthritis	11
Tapering of biological treatment in autoinflammatory diseases: a scoping review	11
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study	11
Exploring physical activity patterns in adolescents with hypermobility spectrum disorder or hypermobile Ehlers-Danlos Syndrome	11
Juvenile dermatomyositis with Anti-SAE antibodies in a Moroccan child associated with pseudo-angioedema: a case report	11
Epstein–Barr Virus encephalitis associated hemophagocytic lymphohistiocytosis in childhood-onset systemic lupus erythematosus: a case-based review	10
Maternal and infant outcomes of pregnancy associated with anti-SSA/RO antibodies: a systematic review and meta-analysis	10
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort	10
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report	10
Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis	9
Structural ultrasound of joints and tendons in healthy children: development of normative data	9
Kawasaki disease in Kenya and review of the African literature	9
Treatment escalation patterns to start biologics in refractory moderate juvenile dermatomyositis among members of the Childhood Arthritis and Rheumatology Research Alliance	9
A qualitative evaluation of the specific carbohydrate diet for juvenile idiopathic arthritis based on children’s and parents’ experiences	9
Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era	9
Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases	9
Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature review	9
A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient	9
Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms	9
A virtual pediatric rheumatology teaching initiative for physicians in Somaliland	9
Hypertension as a prominent manifestation secondary to renal artery lesions in pediatric Behcet’s disease	9
Monogenic disorders as mimics of juvenile idiopathic arthritis	9

Unmet social needs in pediatric rheumatic disease: a study of disparities	8
Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain	8
High prevalence of sacroiliitis and early structural changes in the sacroiliac joint in children with enthesitis-related arthritis: findings from a tertiary centre in Hong Kong	8
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study	8
Correction: Transition readiness among finnish adolescents with juvenile idiopathic arthritis	8
Whole-exome sequencing analysis identifies novel variants associated with Kawasaki disease susceptibility	8
Characterizing lupus in African American children in Southern United States	8
Assay for interferon gamma release as a novel marker in pediatric patients with systemic lupus erythematosus	8
Scurvy masquerading as IgA vasculitis	8
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis	8
Feasibility of applying infrared thermal imaging for home monitoring of arthritis in children	8
Axial involvement in enthesitis-related arthritis: results from a single-center cohort	8
MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes	8
Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis	8
Systemic steroidophobia scale for pediatric rheumatology (SSS-PR): development and validation of a novel psychometric tool measuring clinician steroidophobia	8
Correction: Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases	7
Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report	7
Bone health and physical activity in adolescents with juvenile idiopathic arthritis: a cross-sectional case-control study	7
Vaccination coverage, immune responses, and clinical characteristics in children with PFAPA syndrome: a monocentric prospective study	7
Towards a histological diagnosis of childhood small vessel CNS vasculitis	7
Kawasaki disease with an asymptomatic reversible splenial lesion	7
Paediatric autoimmune diseases with ELANE mutations associated with neutropenia	7
Symptom course of PFAPA syndrome	7
Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination	7
Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research	7
Is an association of acro-osteolysis, bone fragility, and enchondromatosis a newfound disease caused by an amplification of PTHLH? A case report	7
Part 5: Allogeneic HSCT in refractory SJIA with lung disease; recent cases from centers in North America & Europe	7
Prevalence of spine pain among Tunisian children and adolescents and related factors	7
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data	7
Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	7
High rheumatoid factor does not diminish efficacy of TNF inhibitors in seropositive JIA	7
ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis	7
Depression and anxiety in childhood-onset systemic lupus erythematosus: prevalence, associated factors, and impact on quality of life and family	7
Panniculitis with late onset enthesitis-related arthritis: a case report	7
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors	7
Effect of exercise training on heath, quality of life, exercise capacity in juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials	7
Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient	7
Pain-coping scale for children and their parents: a cross-sectional study in children with musculoskeletal pain	7
Correction: Engaging patients and parents to improve mental health intervention for youth with rheumatological disease	6
Proceedings of the 2024 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting	6
Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study	6
Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study	6
Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study	6
Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study	6
What have we learned from long-term studies in juvenile idiopathic arthritis? – Prediction, classification, transition.	6
Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort	6
Association of Mediterranean diet adherence with familial Mediterranean fever severity in a Lebanese cohort	6
Markerless gait analysis for children and adolescents with juvenile idiopathic arthritis using a machine learning pipeline	6
Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey	6
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment	6
Synchronous disease onset and flares in siblings with PFAPA	6
A novel frameshift variant in the ADA2 gene of a patient with a neurological phenotype: a case report	6
Accuracy and adequacy of photoprotection in pediatric systemic lupus erythematosus patients, and the effect of education on photoprotection: a prospective study	6
PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?	6
Bacterial infection in patients with juvenile systemic lupus erythematosus and fever	6
An updated overview of Juvenile systemic sclerosis in a French cohort	6
Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series	6
Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome	6
A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children wit	6
Publisher Correction: Musculoskeletal involvement in childhood leukemia: Characteristics and survival outcomes	6
Juvenile diabetes and systemic sclerosis: just a coincidence?	6
Novel multiple Z-score models for detection of coronary artery dilation: application in Kawasaki disease	6
“I’d like more options!”: Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritis	6
Nailfold videocapillaroscopy in patients with deficiency of adenosine deaminase 2 (DADA2): a case-control study	6
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry	6
Clinical utility of CBC-Derived inflammatory markers for predicting IVIG resistance: findings from a Korean infant Kawasaki disease cohort	6
Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease	6
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature	6
Clinical characteristics and prognosis of interstitial lung disease in systemic juvenile idiopathic arthritis: a two-center retrospective observational cohort study	6
Childhood-onset Takayasu arteritis: clinical presentation, challenges and disease course	5
The 4th NextGen therapies for SJIA and MAS: part 2 phenotypes of refractory SJIA and the landscape for clinical trials in refractory SJIA	5
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study	5
Juvenile dermatomyositis: new insights into pathogenesis and clinical applications	5
Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis	5
A mixed-method systematic review evaluating interventions in paediatric rheumatology to address caregiver support and well-being	5
Quality improvement in juvenile idiopathic arthritis: a mixed-methods implementation pilot of the CAPTURE-JIA dataset	5
Bayesian trial of adalimumab versus secukinumab for children with juvenile idiopathic arthritis associated uveitis or chronic anterior uveitis	5
Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus	5
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders	5
A tale of two regions: comparing clinical features and outcomes in pediatric enthesitis-related arthritis	5

Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study	5
Heart rate variability (HRV) in juvenile fibromyalgia: a preliminary study	5
Neutrophil activation in juvenile dermatomyositis: associations with muscle function and disease progression	5
The relationships of kinesiophobia and physical function and physical activity level in juvenile idiopathic arthritis	5
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis	5
The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?	5
Children’s experiences of a support program during their first year with juvenile idiopathic arthritis	5
The use of ECMO in pediatric granulomatosis with polyangiitis	5
The effect of TNF treatment uptake on incident hospital admission in Western Australia	5
Urinary ALCAM signatures define renal activity and therapeutic response in juvenile lupus nephritis	5
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	5
Muscle mass, strength, and sarcopenia in juvenile idiopathic arthritis: a scoping review	5
Uveitis associated with juvenile arthritis: a continued cohort study 40 years after uveitis onset	5
Lymphocyte apoptosis and its association with the inflammatory markers and disease severity in juvenile-onset systemic lupus erythematosus patients	5
Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies	5
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)	5
Still’s disease: bridging the gap between guidelines and clinical practice	5
C-reactive protein to high density lipoprotein cholesterol ratio for predicting coronary artery lesions, and intravenous immunoglobulin resistance in Kawasaki disease	5
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity	5
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype	5
Kawasaki disease in neonates: a case report and literature review	5
“Online survey of COVID-19 immunization and infection in patients with systemic juvenile idiopathic arthritis and adult-onset still’s disease.”	5
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study	4
Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatment	4
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy	4
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience	4
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease	4
Bridging gaps: a qualitative inquiry on improving paediatric rheumatology care among healthcare workers in Kenya	4
Revising the WHO Essential Medicines List for paediatric rheumatology update	4
Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates	4
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry	4
Colchicine treatment can be discontinued in a selected group of pediatric FMF patients	4
Clinical features of Kawasaki disease initially mimicking retropharyngeal abscess: a retrospective analysis	4
The utility of miR-16, miR-146a and miR-155 in serum and urine for juvenile idiopathic arthritis diagnostics and monitoring	4
New avenues in childhood vasculitis	4
Mental health screening in pediatric rheumatology: a feasibility study	4
Resilience and its associations in children with Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis	4
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review	4
Kawasaki disease complicated by peripheral artery thrombosis: a case report and literature review	4
Juvenile eosinophilic fasciitis: a single center case series	4
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis	4
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice	4
Reverse complete heart block using transcutaneous pacing and repeated plasmapheresis in a neonate with lupus: a case report	4
Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata	4
Unmet needs and research gaps in Still’s disease across ages: proceedings from a pediatric and adult joint expert panel	4
Causal relationship between serum metabolites and juvenile idiopathic arthritis: a mendelian randomization study	4
Efficacy of mycophenolate mofetil for the maintenance therapy of anti-AQP4 antibody-positive NMOSD complying with probable sjögren’s disease in a 2-year-old girl: a case report	4
Clinical outcomes of giant coronary aneurysms in South Asian children with Kawasaki disease	4
Perspectives and experiences of parents of children with juvenile dermatomyositis: a semi-structured interview study	4
Aicardi-Goutières syndrome type 6: report of ADAR variant and clinical outcome after ruxolitinib treatment in the neonatal period	4
Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children	4
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	4
The 4th NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study	4
A quantitative comparison between the essential medicines for rheumatic diseases in children and young people in Africa and the WHO model list	4
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis	4
Clinical profile and long-term outcomes of pediatric-onset Takayasu’s arteritis: data from a mexican national referral center	3
Pediatric-onset limited ANCA-associated vasculitis arising during pre-existing chronic recurrent multifocal osteomyelitis	3
FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood	3
Juvenile idiopathic recurrent parotitis (JIRP) treated with short course steroids, a case series study and one decade follow up for potential autoimmune disorder	3
Identifying circRNA-associated-ceRNA networks in juvenile spondyloarthropathies patients	3
Evidence of persistent glial cell dysfunction in the anterior cingulate cortex of juvenile idiopathic arthritis children: a proton MRS study	3
Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices	3
Lack of HLH in FMF	3
A Chinese child with both systemic lupus erythematosus coexisting with neuromyelitis optica spectrum disorder: a case report	3
Cardiac repolarization abnormalities in children with familial Mediterranean fever	3
Juvenile Sjögren disease: time for age-specific classification criteria	3
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials	3
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva	3
Influenza knowledge and barriers to vaccination in immunosuppressed patients in the pediatric rheumatology clinic	3
Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort	3
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study	3
Pulmonary manifestations of childhood-onset primary Sjogren’s syndrome (SS) masquerading as reactive airways disease in a male patient and review of interstitial lung disease associated with SS	3
Shaping the future of pediatric rheumatology	3
Antibodies to histone in the pediatric population: a retrospective chart review	3
Efficacy of combined JAK1/2 inhibition and cyclosporine in paediatric-onset Still’s disease with lung involvement: a case report	3
Integrative machine learning identifies robust inflammation-related diagnostic biomarkers and stratifies immune-heterogeneous subtypes in Kawasaki disease	3
Resource utilization and costs of transitioning from pediatric to adult care for patients with chronic autoinflammatory and autoimmune disorders	3
Clinical characteristics and risk factors of coronary artery lesions in chinese pediatric Takayasu arteritis patients: a retrospective study	3
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry	3
Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database	3
Significance of differential diagnosis for the elucidation of rare and complicated diseases	3
Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in	3
C1-C2 subluxation in enthesitis-related arthritis: two case reports and literature review of ten cases	3
Immune checkpoint inhibitors and the pediatric rheumatologist: a pediatric needs assessment	3
Factors that influence school attendance and participation in children and adolescents with juvenile idiopathic arthritis - a systematic review of the literature	3
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay	3
Correction to: Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing	3
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans	3
Extreme Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA): a discrete group of patients	3
Retropharyngeal abscess-like as an atypical presentation of Kawasaki disease: a case report and literature review	3
Impact of physiotherapy on orofacial manifestations of juvenile idiopathic arthritis	3
Treat-to-target strategies for the management of familial Mediterranean Fever in children	3
Proceedings from the 4th NextGen Therapies for SJIA and MAS virtual symposium held February 13–14, 2022	3
Expert collaborative evidence-based consensus for childhood lupus nephritis diagnosis and treatment: unifying clinical approach in Saudi Arabia	3
Natural killer cells as biomarkers for disease activity, lupus nephritis, and time to remission in treatment-naïve childhood-onset systemic lupus erythematosus: a cohort study	2